Fundraising Fox
Biossil
Toronto, CA · 7 known investors
Find your way into Biossil
Sign up to see every warm intro you have to Biossil
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biossil team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease. It applies gene embedding analysis to drug discovery, rescue, and repositioning, with active and planned clinical trials across a range of rare and severe indications.
Founders & leadership
Investors · 7
How we know: the company's own site · funding news · press coverage · Not right? Tell us
How we know: Golden Ventures's portfolio page · funding news · press coverage · Not right? Tell us
How we know: Panache Ventures's portfolio page · funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: Staircase Ventures's portfolio page · a partner's Signal profile · funding news · press coverage · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$3.7M disclosed across 1 round · 2026
- $3.7MseedApr 2026
Golden Ventures, Staircase Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Biossil do?
- biossil is an AI-native biopharma company developing late-stage drug programs for life-threatening conditions with unmet needs, including sickle cell disease, idiopathic pulmonary fibrosis, glioblastoma, breast cancer, and Alzheimer's disease. It applies gene embedding analysis to drug discovery, rescue, and repositioning, with active and planned clinical trials across a range of rare and severe indications.
- Who founded Biossil?
- Biossil was founded by Alexander I. Mosa, Anthony Mouchantaf.
- Who are Biossil's investors?
- Biossil's investors include Founders Fund, Golden Ventures, Panache Ventures, Staircase Ventures, 137 Ventures, DRI Healthcare, Quiet Capital.
- How much funding has Biossil raised?
- Biossil has disclosed $3.7M raised across 1 round.
- Where is Biossil headquartered?
- Biossil is headquartered in Toronto, CA.